Transport of CSF antibodies to Gα subunits across neural membranes requires binding to the target protein and protein kinase C activity

Molecular Brain Research

Volumn 65, Issue 2, 1999, Pages 151-166

  Garzón, Javier ^a   DeFelipe, Javier ^a   Rodríguez, José Rodrigo ^a   DeAntonio, Isabel ^a   García España, Antonio ^a   Sánchez Blázquez, Pilar ^a  

^a CSIC   (Spain)

Author keywords

Antinociception; G transducer protein; IgGs to G subunit; Protein kinase C activity; Transport of proteins across neural membrane

Indexed keywords

ANTIBODY; ANTISENSE OLIGODEOXYNUCLEOTIDE; GUANINE NUCLEOTIDE BINDING PROTEIN; PROTEIN KINASE C;

ANIMAL EXPERIMENT; ANTINOCICEPTION; ARTICLE; AUTORADIOGRAPHY; CEREBROSPINAL FLUID; ELECTRON MICROSCOPY; ENZYME ACTIVITY; INTERNALIZATION; MALE; MOUSE; NERVE MEMBRANE; NONHUMAN; PRIORITY JOURNAL; PROTEIN TRANSPORT;

ANIMALIA;

EID: 0033525369     PISSN: 0169328X     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0169-328X(98)00350-7     Document Type: Article

References (65)

1. Aihara N., Tanno H., Hall J.J., Pitts H.L., Nobel L.J. Immunocytochemical localization of immunoglobulins in the rat brain: relationship to the blood-brain barrier. J. Comp. Neurol. 342:1994;481-496.
2. i3. Science. 262:1993;1569-1572.
3. iα in the basal ganglia reveals its potential role in both signal transduction and vesicle trafficking. J. Neurosci. 12:1992;3435-3444.
4. Beltinger C., Saragovi H.U., Smith R.M., LeSauteur L., Shah N., DeDionisio L., Christensen L., Raible A., Jarett L., Gewirtz A.M. Binding, uptake, and intracellular trafficking of phosphorothioate-modified oligodeoxynucleotides. J. Clin. Invest. 95:1995;1814-1823.
5. Bickel U., Yoshikawa T., Landaw E.M., Faull K.F., Pardridge W.M. Pharmacologic effects in vivo in brain by vector-mediated peptide drug delivery. Proc. Natl. Acad. Sci. U.S.A. 90:1993;2618-2622.
6. Bollensen E., Albrecht S., Beuche W., Mäder M., Prange H.W. Reactivity of locally produced CSF antibodies in patients with neurosyphilis against antigens of Treponema pallidum. J. Neurol. 240:1993;471-474.
7. Bouillot C., Prochiantz A., Rougon G., Allinquant B. Axonal amyloid precursor protein expressed by neurons in vitro is present in a membrane fraction with caveolae-like properties. J. Biol. Chem. 29:1996;7640-7644.
8. Brightman M.W. The intracerebral movement of proteins injected into blood and cerebrospinal fluid of mice. Prog. Brain Res. 29:1968;19-37.
9. Brightman M.W., Reese T.S. Junctions between intimately apposed cell membranes in the vertebrate brain. J. Cell. Biol. 40:1969;648-677.
10. Cameron P.L., Ruffin J.W., Bollag R., Rasmussen H., Cameron R.S. Identification of caveolin and caveolin-related proteins in the brain. J. Neurosci. 17:1997;9520-9535.
11. Cheklonin V.P., Ryabukhin I.A., Zhirkov Y.A., Kashparov I.A., Dmitriyeva T.B. Transport of hydrophobized fragments of antibodies through the blood-brain barrier. NeuroReport. 7:1995;129-132.
12. Chiasson B.J., Armstrong J.N., Hooper M.L., Murphy P.R., Robertson H.A. The application of antisense oligonucleotide technology to the brain: some pitfalls. Cell. Mol. Neurobiol. 14:1994;507-521.
13. Cooper J.A. Effects of cytochalasin and phalloidin on actin. J. Cell. Biol. 105:1987;1473-1478.
14. Coulter S., Rodbell M. Heterotrimeric G proteins in synaptoneurosome membranes are crosslinked by p-phenylenedimaleimide, yielding structures comparable in size to crosslinked tubulin and F-actin. Proc. Natl. Acad. Sci. U.S.A. 89:1992;5842-5846.
15. i alpha to the nucleus. FASEB J. 5:1991;200-206.
16. z in mouse sciatic nerve: a potential pathway for signal transduction in neurons. Eur. J. Neurosci. 6:1994;626-631.
17. DeFelipe J., Fairén A. A simple and reliable method for correlative light and electron microscopic studies. J. Histochem. Cytochem. 41:1993;769-772.
18. Friden P.M., Walus L.R., Watson P., Doctrow S.R., Kozarich J.W., Bäckman C., Bergman H., Hoffer B., Bloom F., Granholm A.C. Blood-brain barrier penetration and in vivo activity of a NGF conjugate. Science. 259:1993;373-377.
19. Garzón J. Cellular transduction regulated by μ- and δ-opioid receptors in supraspinal analgesia: GTP binding regulatory proteins as pharmacological targets. Analgesia. 1:1995;131-144.
20. x/z- and Gq-transducer proteins in the production of analgesia in the mouse. Analgesia. 1:1995;429-432.
21. x/z transducer proteins in mouse periaqueductal gray matter. J. Pharmacol. Exp. Ther. 281:1997;549-557.
22. i2 transducer proteins. Life Sci. Pharmacol. Lett. 55:1994;PL205-212.
23. m GTPase activity in mouse periaqueductal grey matter. Eur. J. Neurosci. 9:1997;1194-1200.
24. Hastings R.H., Wright J.R., Albertine K.H., Ciriales R., Matthay A. Effect of endocytosis inhibitors on alveolar clearance of albumin, immunoglobulin G, and SP-A in rabbits. Am. J. Physiol. 266:1994;L544-L552.
25. Helms J.B. Role of heterotrimeric GTP binding proteins in vesicular protein transport: indications for both classical and alternative G protein cycles. FEBS Lett. 369:1995;84-88.
26. Katada T., Ui M. Direct modification of the membrane adenylate cyclase system by islet-activating protein due to ADP-ribosylation of a membrane protein. Proc. Natl. Acad. Sci. U.S.A. 79:1982;3129-3133.
27. Kleuss C., Hescheler J., Ewel C., Rosenthal W., Schultz G., Wittig B. Assignment of G-protein subtypes to specific receptors inducing inhibition of calcium currents. Nature. 353:1991;43-48.
28. Knopf J.L., Lee M.H., Sultzman L.A., Kriz R.W., Loomis C.R., Hewick R.M., Bell R.M. Cloning and expression of multiple protein kinase C cDNAs. Cell. 46:1986;491-502.
29. Kozlowski G.P., Sterzl I., Nilaver G. Localization patterns for immunoglobulins and albumins in the brain suggest diverse mechanisms for their transport across the blood-brain barrier (BBB). Prog. Brain Res. 91:1992;149-154.
30. Kristensson K., Olsson Y. Retrograde axonal transport of protein. Brain Res. 29:1971;363-365.
31. Leyte A., Barr B.A., Kehlenbach R.H., Huttner W.B. Multiple trimeric G-proteins on the trans-Golgi network exert stimulatory and inhibitory effects on secretory vesicle formation. EMBO J. 11:1992;4795-4804.
32. Li S., Okamoto T., Chun M., Sargiacomo M., Casanova J.E., Hansen S.H., Nishimoto I., Lisanti M.P. Evidence for a regulated interaction between heterotrimeric G proteins and caveolin. J. Biol. Chem. 270:1995;15693-15701.
33. Lisanti M.P., Scherer P.E., Tang Z., Sargiacomo M. Caveolae, caveolin and caveolin-rich membrane domains: a signaling hypothesis. Trends Cell. Biol. 4:1994;231-235.
34. 2+ currents in rat anterior pituitary cells. Neuron. 8:1992;455-463.
35. McFadzean I., Mullaney I., Brown D.A., Milligan G. Antibodies to the GTP binding protein Go, antagonize noradrenaline-induced calcium current inhibition in NG108-15 hybrid cells. Neuron. 3:1989;177-182.
36. Monier S., Parton R.G., Vogel F., Henske A., Kurzchalia A. VIP21-caveolin, a membrane protein constituent of the caveolar coat, forms high molecular mass oligomers in vivo and in vitro. Mol. Biol. Cell. 6:1995;911-927.
37. Nishimoto I., Okamoto T., Matsuura Y., Takahashi S., Okamoto T., Murayama Y., Ogata E. Alzheimer amyloid protein precursor complexes with brain GTP-binding protein Go. Nature. 362:1993;75-79.
38. i2, in membranes of neuroblastoma×glioma (NG108-15) cells. J. Biol. Chem. 266:1991;3365-3368.
39. Ono Y., Kikkawa U., Ogita K., Fujii T., Kurokawa T., Asaoka Y., Sekiguchi K., Ase K., Igarashi K., Nishizuka Y. Expression and properties of two types of protein kinase C: alternative splicing from a single gene. Science. 236:1987;1116-1120.
40. Ono Y., Kurokawa T., Fujii T., Kawahara K., Igarashi K., Kikkawa U., Ogita K., Nishizuka Y. Two types of complementary DNAs of rat brain protein kinase C. FEBS Lett. 206:1986;347-352.
41. Panegyres P.K. The amyloid precursor protein gene: a neuropeptide gene with diverse functions in the central nervous system. Neuropeptides. 31:1997;523-535.
42. Pappas G.D., Purpura D.P. Distribution of colloidal particles in extracellular space and synaptic cleft substance of mammalian cerebral cortex. Nature. 210:1966;1391-1394.
43. Parton R.G. Caveolae and caveolins. Curr. Opinion Cell Biol. 8:1996;542-548.
44. Parton R.G., Joggerst B., Simons K. Regulated internalization of caveolae. J. Cell. Biol. 127:1994;1199-1215.
45. Pastan I., Willingham M., Amderson W., Gallo M. Localization of serum-derived alpha 2 macroglobulin in cultured cells and decrease after Moloney sarcoma virus transformation. Cell. 12:1977;609-617.
46. o in choroidal and ciliated ependymocytes. J. Neurosci. 9:1989;806-814.
47. Raffa R.B., Martínez R.P., Connelly C.D. G-protein antisense oligodeoxynucleotides and μ-opioid supraspinal antinociception. Eur. J. Pharmacol. 258:1994;R5-7.
48. Rose-John S., Dietrich A., Marks F. Molecular cloning of mouse protein kinase C (PKC) cDNA from Swiss 3T3 fibroblasts. Gene. 74:1988;465-471.
49. Rossi G.C., Standifer K.M., Pasternak G.W. Differential blockade of morphine and morphine-6β-glucuronide analgesia by antisense oligodeoxynucleotides directed against MOR-1 and G-protein α subunits in rats. Neurosci. Lett. 198:1995;99-102.
50. Sánchez-Blázquez P., García-España A., Garzón J. In vivo injection of oligodeoxynucleotides to Gα subunits and supraspinal analgesia evoked by mu and delta opioid agonists. J. Pharmacol. Exp. Ther. 275:1995;1590-1596.
51. Sánchez-Blázquez P., García-España A., Garzón J. Antisense oligodeoxynucleotides to opioid mu and delta receptors reduced morphine dependence in mice: role of delta-2 opioid receptors. J. Pharmacol. Exp. Ther. 280:1997;1423-1431.
52. Sánchez-Blázquez P., Garzón J. Delta-opioid receptor subtypes activate inositol-signaling pathways in the production of antinociception. J. Pharmacol. Exp. Ther. 285:1998;820-827.
53. i2 transducer proteins on μ/δ opioid-mediated supraspinal antinociception. Life Sci. Pharmacol. Lett. 53:1993;PL381-386.
54. x/z transducer proteins impair the supraspinal antinociceptive effect of neurotensin and clonidine in mice. Analgesia. 2:1996;117-123.
55. Sargiacomo M., Sudol M., Tang Z.L., Lisanti M.P. Signal transducing moleculaes and glycosyl-phosphatidylinositol-linked proteins form a caveolin-rich insoluble complex in MDCK cells. J. Cell. Biol. 122:1993;789-807.
56. i2-mediates α2-adrenergic inhibition of adenylate cyclase in platelet membranes: in situ identification with Gα C-terminal antibodies. Proc. Natl. Acad. Sci. U.S.A. 86:1989;7809-7813.
57. Standifer K.M., Rossi G.C., Pasternak G.W. Differential blockade of opioid analgesia by antisense oligodeoxynucleotides directed against various G protein α subunits. Mol. Pharmacol. 50:1996;293-298.
58. Stein C.A., Tonkinson J.L., Zhang L.M., Yakubov L., Gervasoni J., Taub R., Rotenberg S.A. Dynamics of the internalization of phosphodiester oligodeoxynucleotides in HL60, cells. Biochemistry. 32:1993;4855-4861.
59. Stenseth K., Thyberg J. Monensin and chloroquine inhibit transfer to lysosomes of endocytosed macromolecules in cultured mouse peritoneal macrophages. Eur. J. Cell. Biol. 49:1989;326-333.
60. Triguero D., Buciak J.B., Yang J., Pardridge W.M. Blood-brain barrier transport of cationized immunoglobulin G: enhanced delivery compared to native protein. Proc. Natl. Acad. Sci. U.S.A. 86:1989;4761-4765.
61. van Renswoude J., Bridges K.R., Harford J., Klausner R.D. Receptor-mediated endocytosis of transferrin and the uptake of fe in K562 cells: identification of a nonlysosomal acidic compartment. Proc. Natl. Acad. Sci. U.S.A. 79:1982;6186-6190.
62. iα1. J. Biol. Chem. 265:1990;1239-1242.
63. Willingham M.C., Hanover J.A., Dickson R.B., Pastan I. Morphologic characterization of the pathway of transferrin endocytosis and recycling in human KB cells. Proc. Natl. Acad. Sci. U.S.A. 80:1984;175-179.
64. Yakubov L.A., Deeva E.A., Zarytova V.F., Ivanova E.M., Ryte A.S., Yurchenko L.V., Vlassov V.V. Mechanism of oligonucleotide uptake by cells: involvement of specific receptors? Proc. Natl. Acad. Sci. U.S.A. 86:1989;6454-6458.
65. Zlokovic B.V., Skundric D.S., Segal M.B., Lipovac M.N., Mackic J.B., Davson H. A saturable mechanism for transport of immunoglobulin G across the blood-brain barrier of the guinea pig. Exp. Neurol. 107:1990;263-270.